NNelo Trade
← Back to Market News
November 06, 2026 at 01:31 PM UTC

CG Oncology, Inc. reports financial results in SEC 8-K

CG Oncology, Inc. filed an 8-K covering results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: November 06, 2026 at 01:30 PM UTC

Open official source
CG Oncology, Inc. reports financial results in SEC 8-K | Nelo Trade